Global R&D used to be understood mainly as offshoring or a way to tap into cheaper labor. Today, though, it’s far more than simply extending R&D activities overseas — it has become a multifaceted framework that requires systematic operation and management across countries, languages, cultures, and time zones.
Traditional R&D was largely in-house, aimed at new product development or service improvement — academia focused on basic research, industry on applied and development research, both bearing the associated risk and uncertainty. Global R&D, however, serves a broader purpose. Beyond cost reduction, it secures new sources of knowledge and experience, opens access to diverse markets, and develops products tailored to local customer needs — motivations that are more strategic and materially meaningful to a company.
I’d break Global R&D down into three categories.
First, running overseas technology centers.
These are established to tap into global innovation resources, pursuing local knowledge exploration (innovative R&D) and market adaptation (adaptive R&D) at the same time. Many started out purely to cut costs, but over time more of them are being entrusted with global product development based on the local capability they’ve built. The upfront cost of setting up an overseas research center is genuinely enormous. You have to integrate the local team into the company’s culture, align them on ways of working, help them sharpen the areas they’re already strong in, and, from a mid-to-long-term view, keep assigning and nurturing projects that raise their technical maturity. Only after that can their intrinsic capability compound into organizational capability, translating into technical leadership and sustained innovation. It sounds straightforward described this way, but in practice none of these steps is easy without a clear line connecting short-, medium-, and long-term goals and purpose.
Second, global collaboration and joint development.
Technology keeps getting more complex. The knowledge and skills needed to develop a single product or service are far broader and more specialized than they used to be. At the same time, R&D costs keep rising, making it harder for any one company to carry all the innovation on its own. Against this backdrop, Open Innovation is becoming increasingly important. Companies can no longer rely solely on internal resources and need to absorb new ideas and knowledge through outside collaboration. Innovation partners now go well beyond internal research teams to include academia, government bodies, startups, and even competitors. Because complex problems can only be solved and new opportunities created by combining the expertise and resources of different actors, open innovation is a strategic choice, not just cooperation for its own sake. It spreads R&D risk, broadens the pool of ideas, and speeds up product development — clear enough advantages that I expect OI to keep accelerating and broadening in scope going forward.
Third, digitally enabled virtual R&D.
Digital transformation is fundamentally reshaping how global R&D operates. Collaboration that once required people to be physically in the same room now crosses borders and time zones with ease. Cloud-based research environments let teams share and analyze research data from anywhere in the world, and remote collaboration tools let teams on different continents run a project in real time as if they were in the same office — a shift that accelerated further post-pandemic and has become something of a collaboration standard. This shift is already producing visible results. A multinational pharmaceutical company, for example, used a remote collaboration platform so that a drug candidate designed by its U.S. research team could be validated in a lab in India, while a European team analyzed the data and designed the clinical studies — cutting development time significantly. This kind of global collaboration structure doesn’t just improve efficiency; it translates directly into more patent filings and stronger innovation output.
AI-driven research is opening yet another turning point on top of this. Some leading companies and labs are already turning the concept of self-driving labs into reality, where AI proposes experiment designs, robots run the experiments, and AI analyzes the results. A Canadian startup combined AI and robotics to automate new-material synthesis experiments, cutting research time from months to days. In pharma, more cases are emerging of AI simulating billions of compound combinations to surface promising drug candidates. As AI and robotics keep advancing, AI will move beyond being a mere tool and become an agent that reshapes the paradigm of R&D itself. We’re heading toward an era where, instead of researchers forming hypotheses and designing experiments, AI continuously learns from data and iterates through experiments to surface new possibilities — making global R&D faster and more flexible, and helping companies dramatically shorten their innovation cycles.
That last point — self-driving labs where AI does the analysis — is something I haven’t experienced firsthand, so I’m genuinely curious about it, and I find myself thinking it would be worth being part of driving that kind of change if the opportunity ever comes up.
I’ll wrap up here for today. I’d originally planned to also cover the components of Global R&D, but this post has already run long, so I’ll save that for next time.
#GlobalRnD #InnovationManagement #OpenInnovation #DigitalTransformation #ArtificialIntelligence #GlobalCollaboration #FutureOfInnovation #Leadership